Rapporto sull’analisi delle dimensioni del mercato del trattamento delle malattie infiammatorie intestinali e delle quote | Previsioni 2031

  • Report Code : TIPRE00003491
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

PANORAMICA DEL MERCATO

Malattia infiammatoria intestinale (IBD) è un termine che è usato per descrivere i disturbi che comportano l'infiammazione cronica del tratto digestivo. I due tipi di IBD includono vale a dire la colite ulcerosa e il morbo di Crohn che di solito comportano grave diarrea, dolore addominale, affaticamento e perdita di peso. Il trattamento dell'IBD consiste nel ridurre l'infiammazione che innesca i segni e i sintomi. Il trattamento prevede la terapia farmacologica o l'intervento chirurgico. La terapia farmacologica include farmaci antinfiammatori che includono inoltre corticosteroidi e aminosalicilati come mesalamina (Asacol HD, Delzicol, altri), balsalazide (Colazal) e olsalazina (Dipentum), a seconda dell'area interessata del colon.< /p>

AMBITO DI MERCATO

The

"Infiammatorio Globale" L'analisi del mercato del trattamento delle malattie intestinali fino al 2028"

è uno studio specializzato e approfondito del settore dei dispositivi medici con particolare attenzione all'analisi delle tendenze del mercato globale. L’obiettivo del rapporto è fornire una panoramica del mercato del trattamento delle malattie infiammatorie intestinali con una segmentazione dettagliata del mercato per tipo di classe di farmaco, indicazione della malattia, canale di distribuzione e area geografica. Il rapporto fornisce statistiche chiave sullo stato del mercato dei principali attori del mercato Trattamento delle malattie infiammatorie intestinali e offre tendenze e opportunità chiave nel mercato.

SEGMENTAZIONE DEL MERCATO

  • In base al tipo di classe di farmaci, il mercato è segmentato in aminosaliciclati, immunomodulatori, inibitori del TNF e corticosteroidi.
  • Sulla base dell'indicazione della malattia, il mercato è segmentato in morbo di Crohn e colite ulcerosa
  • In base al canale di distribuzione, il mercato globale del trattamento delle malattie infiammatorie intestinali è classificato come farmacia ospedaliera, farmacia online e farmacia al dettaglio.
< p>

DINAMICHE DEL MERCATO

Driver:

  • Presenza di forti prodotti in pipeline per il trattamento della malattia infiammatoria intestinale (IBD)
  • Crescente prevalenza della malattia di Crohn e della colite ulcerosa

Restrizioni:

  • Costo elevato del trattamento

QUADRO REGIONALE

Il rapporto fornisce una panoramica dettagliata del settore, comprese informazioni sia qualitative che quantitative. Fornisce una panoramica e previsioni del mercato globale in base a vari segmenti. Fornisce inoltre le dimensioni del mercato e stime previsionali per l’anno 2019-2028 rispetto a cinque principali regioni, vale a dire: Nord America, Europa, Asia-Pacifico (APAC), Medio Oriente e Africa (MEA) e America del Sud. Il mercato del trattamento delle malattie infiammatorie intestinali per ciascuna regione viene successivamente suddivisa in sottosegmenti in base ai rispettivi paesi e segmenti. Il rapporto copre l'analisi e le previsioni di 18 paesi a livello globale insieme alla tendenza attuale e alle opportunità prevalenti nella regione.

Il rapporto analizza i fattori che influenzano il mercato sia dal lato della domanda che dell'offerta e valuta ulteriormente le dinamiche di mercato che influenzano il mercato durante il periodo di previsione, ovvero fattori trainanti, restrizioni, opportunità e tendenza futura. Il rapporto fornisce inoltre un'analisi PEST esaustiva per tutte e cinque le regioni, vale a dire; Nord America, Europa, APAC, MEA e Sud America, dopo aver valutato i fattori politici, economici, sociali e tecnologici che influenzano il mercato del trattamento delle malattie infiammatorie intestinali in queste regioni.

IMPATTO DEL COVID-19 SUL MERCATO DEL TRATTAMENTO DELLE MALATTIE INFIAMMATORIE DELL'INTESTINO

COVID-19 è iniziato per la prima volta a Wuhan (Cina) nel dicembre 2019 e da allora si è diffuso rapidamente in tutto il mondo. mondo. Stati Uniti, India, Brasile, Russia, Francia, Regno Unito, Turchia, Italia e Spagna sono alcuni dei paesi più colpiti in termini di casi confermati e decessi segnalati. La pandemia di COVID-19 ha aumentato la domanda di malattie infiammatorie intestinali trattamento in tutto il mondo.

A causa della situazione relativa al COVID 19, molte aziende si sono concentrate sullo sviluppo di vaccini, prodotti biologici e farmaci efficaci per prevenire/curare la malattia. Tuttavia, a causa A causa del rallentamento dello sviluppo e della produzione di altri prodotti farmaceutici o biologici, unito all'interruzione della catena di approvvigionamento, il mercato ha registrato difficoltà nel 2020.  Inoltre, a causa delle numerose limitazioni imposte dal lockdown, le cure per i bambini affetti da IBD sono state mantenute a standard minimi, dare priorità alle emergenze e alle infusioni di farmaci biologici e implementare servizi di telemedicina.

ATTORI DEL MERCATO

Il rapporto copre gli sviluppi chiave nel mercato del trattamento delle malattie infiammatorie intestinali come strategie di crescita organica e inorganica. Varie aziende si stanno concentrando su strategie di crescita organica come lanci di prodotti, approvazioni di prodotti e altro come brevetti ed eventi. Le attività di strategie di crescita inorganica testimoniate nel mercato sono state acquisizioni e partnership e collaborazioni. Queste attività hanno aperto la strada all'espansione del business e della base di clienti degli operatori del mercato. Sono attesi i pagatori del mercato del mercato del trattamento delle malattie infiammatorie intestinali alle opportunità di crescita redditizie in futuro con la crescente domanda di trattamenti per le malattie infiammatorie intestinali nel mercato globale.

Il rapporto include anche i profili delle principali aziende insieme alle loro analisi SWOT e strategie di mercato nel mercato del trattamento delle malattie infiammatorie intestinali. Inoltre, il rapporto si concentra sui principali attori del settore con informazioni quali profili aziendali, componenti e servizi offerti, informazioni finanziarie degli ultimi 3 anni, lo sviluppo chiave degli ultimi cinque anni.

  • Pfizer Inc.
  • Novartis AG
  • JOHNSON e JOHNSON (Janssen Global Services, LLC)
  • AbbVie Inc.
  • Takeda Pharmaceutical Company Limited
  • ALLERGAN
  • CELGENE CORPORATION
  • Bausch Health
  • UCB, Inc.
  • Cosmo Pharmaceuticals NV

Il team dedicato di ricerca e analisi di Insight Partner è composto da professionisti esperti con competenze statistiche avanzate e offre varie opzioni di personalizzazione nello studio esistente.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is inflammatory bowel disease?

Inflammatory bowel disease" (IBD) is a chronic inflammatory condition of the gastrointestinal tract, including Crohn's disease and ulcerative colitis. These conditions cause inflammation of the digestive tract lining, leading to symptoms like abdominal pain, diarrhea, fatigue, and weight loss. Treatment aims to reduce inflammation, manage symptoms, and prevent complications through medication, lifestyle changes, and sometimes surgery. Managing IBD typically requires ongoing medical care and monitoring to maintain remission and improve quality of life.

What factors drive the Inflammatory Bowel Disease Treatment Market?

The key factors driving the Inflammatory Bowel Disease Treatment Market growth are the rising prevalence of crohn's disease and ulcerative colitis and increasing product launches over the projection period. Inflammatory Bowel Disease Treatment Market trends include the technological advancement in IBD treatment. Furthermore, the development of innovative treatments through continuing research as well as encouraging government initiatives are also expected to fuel the market growth.

Who are the major players in the Inflammatory Bowel Disease Treatment Market?

The Inflammatory Bowel Disease Treatment Market has major market players, including AbbVie Inc, Takeda Pharmaceutical Company Limited, Pfizer Inc, Biogen, Novartis AG, Lilly, UCB S.A., CELLTRION INC., Merck & Co., Inc., and Johnson & Johnson Services, Inc.

What was the estimated Inflammatory Bowel Disease Treatment Market size in 2023?

The Inflammatory Bowel Disease Treatment Market was valued at US$ 24.05 billion in 2023.

What are the growth estimates for the Inflammatory Bowel Disease Treatment Market till 2031?

The Inflammatory Bowel Disease Treatment Market is expected to be valued at US$ 31.67 billion in 2031.

Which drug class segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on drug class, the market is segmented into biologics, aminosalicyclates, corticosteroids, and others. The biologics segment held the largest Inflammatory Bowel Disease Treatment Market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.

Which disease indication segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on disease indication, the Inflammatory Bowel Disease Treatment Market is segmented into crohn's disease and ulcerative colitis. The crohn's disease segment is anticipated to hold a significant share by 2031.

The List of Companies - Inflammatory Bowel Disease Treatment Market

  1. AbbVie Inc
  2. Takeda Pharmaceutical Company Limited
  3. Pfizer Inc
  4. Biogen
  5. Novartis AG
  6. Lilly
  7. UCB S.A.
  8. CELLTRION INC.
  9. Merck & Co., Inc.
  10. Johnson & Johnson Services, Inc.
  11. Mindray Medical International Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports